SciELO - Scientific Electronic Library Online

 
vol.48 issue3Lifelines and acute myocardial infarction: men experiences in Bogotá cityQuality control of human biological material for use in research author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la Universidad Industrial de Santander. Salud

Print version ISSN 0121-0807

Abstract

MORALES L, Liliana A.; RINCON R, Diego F.  and  RINCON OROZCO, Bladimiro. Advances in the development of new prophylactic and therapeutic vaccines against Human Papillomavirus. Rev. Univ. Ind. Santander. Salud [online]. 2016, vol.48, n.3, pp.385-391. ISSN 0121-0807.  https://doi.org/10.18273/revsal.v48n3-2016012.

Prophylactic vaccines against high risk HPV has become important because of the high oncogenic potential of the virus and its association with cervical cancer development, one of the most common and fatal cancers among women worldwide. The objective of this article is describe the state of the art of the current prophylactic and therapeutic HPV vaccines, analyzing their characteristics, advantages, disadvantages and scientific reports on its use and safety in the population. A systematic revision of the latest advances in the development of prophylactic and therapeutic vaccines against HPV was performed. Prophylactic vaccination is effective and essential for the prevention of uterine cervical cancer; new therapeutic vaccines have been shown at the initial phases to be promising contributing in the regression of premalignant or malignant in situ lesions.

Keywords : HPV; Human Papilloma Virus; HPV-16; HPV-18; HPV Vaccine; Cervical Cancer.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )